Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Bone Formation by Endochondral Ossification

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Health-enabling initiatives in food retail and co-creation attitudes from a community of practice in Australia.

Perspectives in public health·2025

Same author

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Same author

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Same author

Conversion of dietary polyunsaturated fats between humans and rodents: A review of allometric scaling models.

Prostaglandins, leukotrienes, and essential fatty acids·2020

Same author

Renegotiation of identity in young adults with cancer: A longitudinal narrative study.

International journal of nursing studies·2019

Same author

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Same journal

Developmental and behavioral profile in a domestic adoptees sample: a new challenge for the pediatrician.

Minerva pediatrica·2020

Same journal

A new approach to the diagnosis of short stature.

Minerva pediatrica·2020

Same journal

Management of the main endocrine and diabetic disorders in children.

Minerva pediatrica·2020

Same journal

Kounis Syndrome: a pediatric perspective.

Minerva pediatrica·2020

Same journal

Human inborn errors of immunity caused by defects of receptor and proteins of cellular membrane.

Minerva pediatrica·2020

Same journal

Tall stature in children and adolescents.

Minerva pediatrica·2020

See all related articles

Search research articles

Related Experiment Video

Updated: May 12, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Controversies in childhood osteosarcoma.

S Bielack¹, B Kempf-Bielack, T Von Kalle

¹Departments of Oncology, Klinikum Stuttgart, Olgahospital, Stuttgart, Germany. coss@olgahospital-stuttgart.de

Minerva Pediatrica

|April 25, 2013

Summary

This summary is machine-generated.

Osteosarcoma treatment combines surgery and chemotherapy, but outcomes depend on tumor response. Ongoing research explores new therapies and imaging to improve survival for this common childhood bone cancer.

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Related Experiment Videos

Last Updated: May 12, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Area of Science:

Pediatric Oncology
Skeletal Tumors
Medical Imaging

Background:

Osteosarcoma is the most common bone cancer in children and adolescents.
Pulmonary metastasis is a primary cause of mortality if not treated effectively.
Current treatment involves surgery and multidrug chemotherapy, with imaging playing a key role.

Purpose of the Study:

To review current diagnostic and treatment strategies for osteosarcoma.
To highlight challenges in imaging interpretation and surgical reconstruction in pediatric patients.
To discuss prognostic factors and future therapeutic directions.

Main Methods:

Review of diagnostic imaging modalities (X-ray, MRI, CT) for primary tumor and metastasis.
Discussion of standard chemotherapy regimens (methotrexate, doxorubicin, cisplatin, ifosfamide).
Analysis of surgical options including limb-sparing techniques, endoprostheses, rotation-plasty, and amputation.

Main Results:

Histologic response to neoadjuvant chemotherapy is a critical prognostic indicator.
Imaging can predict treatment response but has limitations.
The EURAMOS-1 trial is pending to evaluate treatment modification based on response.

Conclusions:

Effective management of osteosarcoma requires a multidisciplinary approach.
Advances in imaging and surgical reconstruction are crucial for improving outcomes in pediatric patients.
Continued follow-up is essential for detecting late treatment effects and recurrences.